首页> 美国卫生研究院文献>Proceedings (Baylor University. Medical Center) >Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients
【2h】

Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients

机译:绝症患者起搏器和植入式心脏除颤器设备管理中的实践和道德考量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

More than 4.5 million people worldwide live with an implanted pacemaker, including >3 million in the USA alone. Also, >0.8 million people in the USA have an implantable cardioverter defibrillator (ICD). Knowing the principles of managing these devices towards the end of life is important, as the interruption of their function may have serious consequences. This article provides health care providers who are not specialized in cardiac electrophysiology with an introduction to the general principles of management of pacemakers or ICD devices towards the end of life, with a suggested algorithm for approaching this process. Also discussed are pertinent ethical and practical considerations in deciding on and implementing a management strategy for these devices during terminal illnesses.
机译:全球有450万人使用植入式起搏器,其中仅在美国就有300万人。同样,在美国,有超过80万人拥有植入式心脏复律除颤器(ICD)。了解使用寿命即将结束时管理这些设备的原理很重要,因为中断其功能可能会造成严重后果。本文向不专门从事心脏电生理学的医疗保健提供者介绍了生命周期即将结束时起搏器或ICD设备管理的一般原则,并提供了一种建议的算法来解决这一问题。在确定和实施这些设备在绝症期间的管理策略时,还将讨论有关的道德和实践考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号